Thiamine Hydrochloride
- Product NDC
- 72603-565
- Requested package NDC
- 72603-565-25
- 11-digit product format
- 726030565
- Labeler code
- 72603
- Product ID
- 72603-565_58bf1607-7d99-2956-e063-6294a90a5ea7
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Thiamine Hydrochloride
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAMUSCULAR; INTRAVENOUS
- Labeler
- NorthStar RxLLC
- Application
- ANDA218471
- Marketing category
- ANDA
- Marketing start
- 2026-10-14
- Substance
- THIAMINE HYDROCHLORIDE
- Active strength
- 100 mg/mL
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A218471-001 | THIAMINE HYDROCHLORIDE | THIAMINE HYDROCHLORIDE | 100MG/ML | INJECTABLE / INJECTION | AP | 2024-11-06 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A218471-001 | AP |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-11-14 07:37:17 | 2026-10 | A218471-001 | THIAMINE HYDROCHLORIDE | 100MG/ML | INJECTABLE / INJECTION | AP | 2024-11-06 | d4dbc9d85df4… | |
| 2026-10-15 13:18:30 | 2026-09 | A218471-001 | THIAMINE HYDROCHLORIDE | 100MG/ML | INJECTABLE / INJECTION | AP | 2024-11-06 | c2088c7a36db… | |
| 2026-09-14 22:38:34 | 2026-08 | A218471-001 | THIAMINE HYDROCHLORIDE | 100MG/ML | INJECTABLE / INJECTION | AP | 2024-11-06 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A218471-001 | THIAMINE HYDROCHLORIDE | 100MG/ML | INJECTABLE / INJECTION | AP | 2024-11-06 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A218471-001 | THIAMINE HYDROCHLORIDE | 100MG/ML | INJECTABLE / INJECTION | AP | 2024-11-06 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A218471-001 | THIAMINE HYDROCHLORIDE | 100MG/ML | INJECTABLE / INJECTION | AP | 2024-11-06 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A218471-001 | THIAMINE HYDROCHLORIDE | 100MG/ML | INJECTABLE / INJECTION | AP | 2024-11-06 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A218471-001 | THIAMINE HYDROCHLORIDE | 100MG/ML | INJECTABLE / INJECTION | AP | 2024-11-06 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A218471-001 | THIAMINE HYDROCHLORIDE | 100MG/ML | INJECTABLE / INJECTION | AP | 2024-11-06 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A218471-001 | THIAMINE HYDROCHLORIDE | 100MG/ML | INJECTABLE / INJECTION | AP | 2024-11-06 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A218471-001 | THIAMINE HYDROCHLORIDE | 100MG/ML | INJECTABLE / INJECTION | AP | 2024-11-06 | 2680178bc6a6… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A218471-001 | THIAMINE HYDROCHLORIDE | 100MG/ML | INJECTABLE / INJECTION | AP | 2024-11-06 | d8e5a09893c0… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A218471-001 | THIAMINE HYDROCHLORIDE | 100MG/ML | INJECTABLE / INJECTION | AP | 2024-11-06 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-11-14 07:37:17 | 2026-10 | A218471-001 | AP | 1 | d4dbc9d85df4… |
| 2026-10-15 13:18:30 | 2026-09 | A218471-001 | AP | 1 | c2088c7a36db… |
| 2026-09-14 22:38:34 | 2026-08 | A218471-001 | AP | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A218471-001 | AP | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A218471-001 | AP | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A218471-001 | AP | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A218471-001 | AP | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A218471-001 | AP | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A218471-001 | AP | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A218471-001 | AP | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A218471-001 | AP | 1 | 2680178bc6a6… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A218471-001 | AP | 1 | d8e5a09893c0… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A218471-001 | AP | 1 | a50c72e98297… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Thiamine Hydrochloride
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| THIAMINE HYDROCHLORIDE | 100 mg/mL |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| M572600E5P | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 313324 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| c4896996-cac8-44df-aa36-82e2b567c3b6 | Available on FDA.report |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Thiamine Hydrochloride | THIAMINE HYDROCHLORIDE | NorthStar RxLLC | c4896996-cac8-44df-aa36-82e2b567c3b6 | 2026-08-11 | Warnings, Adverse reactions | 218471 ANDA218471 72603-565-25 72603-565 72603056525 |
| Thiamine Hydrochloride | THIAMINE HYDROCHLORIDE | Camber Pharmaceuticals, Inc. | 2d402a31-3240-42a0-bd34-8fccd6a792d3 | 2025-02-03 | Warnings, Adverse reactions | 218471 ANDA218471 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|
| 72603-565-25 | 72603056525 | 25 VIAL, MULTI-DOSE in 1 CARTON (72603-565-25) / 2 mL in 1 VIAL, MULTI-DOSE (72603-565-01) | 2026-10-14 | No | No | Current |